| Stage | BEN | % of rev | BX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.4B | 100.00% | $5.0B | 100.00% | BX ×2.14 |
| Gross profit | $1.4B | 59.36% | $5.0B | 100.00% | BX +40.6pp |
| Operating income | $216M | 9.15% | $2.7B | 52.90% | BX +43.8pp |
| Pre-tax income | $371M | 15.73% | $2.8B | 55.68% | BX +40.0pp |
| Net income | $255M | 10.83% | $2.4B | 46.71% | BX +35.9pp |
| Stage | BEN | BX | Gap · A − B |
|---|---|---|---|
| Revenue | $2.4B100.00% | $5.0B100.00% | BX ×2.14 |
| Gross profit | 59.36%$1.4B | 100.00%$5.0B | BX +40.6pp |
| Operating income | 9.15%$216M | 52.90%$2.7B | BX +43.8pp |
| Pre-tax income | 15.73%$371M | 55.68%$2.8B | BX +40.0pp |
| Net income |
| 10.83%$255M |
| 46.71%$2.4B |
| BX +35.9pp |
None
No disclosed counterparties: BEN.